RICKS THOMAS G
SEC CIK 1013023 · EDGAR
BoughtSold
Most active insiders at OVV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Givens Gregory Dean | EVP, COO | — | $4.14M |
| 2 | Eilers Meghan Nicole | EVP, GC, M | — | $634.5K |
| 3 | Moore Rachel Maureen | EVP, Corp. Services | — | $490.9K |
| 4 | Mayson Howard John | Dir | — | $261.9K |
| 5 | NANCE STEVEN W | Dir | — | $209.9K |
| 6 | King Terri Gay | Dir | — | — |
| 7 | Chhina Sippy | Dir | — | — |
| 8 | McCracken Brendan Michael | Pres, CEO, Dir | — | — |
| 9 | Code Corey Douglas | EVP, CFO | — | — |
| 10 | Shaw Brian Gordon | Dir | — | — |
| 15 | RICKS THOMAS G | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-26 17:20 | 2026-05-21 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +3,510 | 103.8K | +3% | — |
| MI | 2025-12-08 | 2025-12-05 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | G - Gift | $0.00 | -3,600 | 92.7K | -4% | $0 |
| D | 2025-05-20 | 2025-05-16 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +5,501 | 100.3K | +6% | — |
| D | 2024-05-21 | 2024-05-17 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +4,213 | 94.8K | +5% | — |
| D | 2024-03-12 | 2024-03-08 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +8,402 | 90.6K | +10% | — |
| D | 2023-07-12 | 2023-07-10 | FTH | Faeth Therapeutics, Inc. | RICKS THOMAS G | Dir | A - Grant | $0.00 | +4,466 | 8,932 | +100% | $0 |
| D | 2023-05-18 | 2023-05-18 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +6,074 | 82.2K | +8% | — |
| D | 2023-03-10 | 2023-03-08 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +14.7K | 76.1K | +24% | — |
| D | 2022-06-14 | 2022-06-10 | FTH | Faeth Therapeutics, Inc. | RICKS THOMAS G | Dir | A - Grant | $0.00 | +4,466 | 4,466 | New | $0 |
| I | 2022-06-08 | 2022-06-07 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | S - Sale | $59.50 | -19.2K | 116.3K | -14% | -$1.14M |
| I | 2022-05-24 | 2022-05-23 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | S - Sale | $50.00 | -10.0K | 135.5K | -7% | -$500.0K |
| D | 2022-05-19 | 2022-05-18 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +4,499 | 61.4K | +8% | — |
| I | 2022-04-19 | 2022-04-18 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | S - Sale | $53.73 | -10.0K | 145.5K | -6% | -$537.3K |
| D | 2022-04-06 | 2022-03-31 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | P - Purchase | — | +19 | 56.9K | +0.0% | — |
| D | 2022-03-09 | 2022-03-08 | OVV | Ovintiv Inc. | RICKS THOMAS G | Dir | M - OptEx | — | +5,184 | 56.9K | +10% | — |
| MI | 2021-12-13 | 2021-12-09+ | FTH | Faeth Therapeutics, Inc. | RICKS THOMAS G | Dir | P - Purchase | $6.24 | +40.0K | 321.8K | +14% | +$249.6K |
Purchase Sale Sale after option exercise All abbreviations